Pirtobrutinib in Covalent BTK-Inhibitor pre-treated relapsed/refractory (R/R) Mantle Cell Lymphoma

Bull Cancer. 2023 Aug 30:S0007-4551(23)00336-3. doi: 10.1016/j.bulcan.2023.07.002. Online ahead of print.NO ABSTRACTPMID:37658026 | DOI:10.1016/j.bulcan.2023.07.002

Source: Bulletin du Cancer - September 1, 2023 Category: Cancer & Oncology Authors: Caroline Fileni Cl émentine Sarkozy Source Type: research